VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BCPC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BCPCBalchem Corporation
$169.21$5.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBCPCBalance Sheet

Balchem Corporation (BCPC) Balance Sheet

30Y historyFree accessUpdated daily

The company has achieved a fortress balance sheet, compressing its debt-to-equity ratio from 0.31 in 2023Q4 to a negligible 0.03 as of 2026Q1.

BCPC Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets388.94M365.61M313.77M314.24M335.8M322.23M266.89M254.95M226.31M199.34M188.44M198.83M181.3M277.77M211.91M175.74M129.65M93.01M55.25M52.47M28.86M35.27M29.21M23.63M18.81M17.02M11.37M9.1M8.4M7.3M5.6M
Cash & Short-Term Investments72.87M74.57M49.52M64.45M66.56M103.24M84.57M65.67M54.27M40.42M38.64M84.8M50.29M208.75M144.74M114.78M77.25M46.43M3.42M2.31M5.19M13M12.73M9.24M1.73M3.12M3.07M1.7M1.3M700K100K
Cash Only72.87M74.57M49.52M64.45M66.56M103.24M84.57M65.67M54.27M40.42M38.64M84.8M50.29M208.75M144.74M114.78M77.25M46.43M3.42M2.31M5.19M13M12.73M9.24M1.73M3.12M3.07M1.7M1.3M700K100K
Short-Term Investments0000000000000000000000000000000
Accounts Receivable154.23M143.6M119.66M125.28M131.58M117.41M98.21M93.44M99.55M91.23M83.25M60.48M71.98M39.39M42M34.43M32.05M29.15M30.25M29.64M11.58M11.52M8M7.23M7.16M7.13M5.04M4M3.3M3.1M3M
Days Sales Outstanding48.7950.5345.849.5750.9653.6350.9552.9956.4555.9854.9339.9648.5342.6449.3943.0645.8648.4847.5861.441.885.0143.342.6743.4156.455.4649.1641.9739.5641.48
Inventory146.74M131.45M130.8M109.52M119.67M91.06M70.62M83.89M67.19M60.7M57.24M46.09M49.62M24.82M20.69M18.64M15.72M13.96M16.62M15.68M9.92M8.54M6.32M5.96M7.24M5.58M2.55M2.7M2.9M2.5M1.9M
Days Inventory Outstanding75.6771.9877.3264.4465.9959.7953.7370.8355.8154.656.1243.7645.637.7934.233.0432.4133.4333.844.2754.1157.2852.953.4371.6272.1254.3863.1767.8559.6450.62
Other Current Assets15.09M16M5.74M7.19M13.09M4.41M3.44M7.55M1.48M2.22M5.19M3.72M4.87M2.24M1.11M954K1.1M1.42M2.38M2.39M416K276K321K474K403K214K200K700K900K1M600K
Total Non-Current Assets1.3B1.34B1.26B1.28B1.29B877.09M898.96M900.74M755.04M764.3M760.18M682.39M679.97M99.1M100.64M95.98M98.97M94.8M99.22M101.95M63.48M39.88M31.19M33.28M34.49M27.45M11.85M12.9M14.2M10.3M9.5M
Property, Plant & Equipment318.2M322.84M299.2M295.9M290.79M246.81M236.51M224.2M194.34M189.79M165.75M158.51M131.59M54.92M52.73M44.28M43.39M41.58M42.51M42.08M31.31M24.4M24.19M25.64M25.85M17.9M7.76M7.8M8.1M7.3M7.5M
Fixed Asset Turnover3.35x3.21x3.19x3.12x3.24x3.24x2.98x2.87x3.31x3.13x3.34x3.49x4.11x6.14x5.89x6.59x5.88x5.28x5.46x4.19x3.22x34.39x2.79x2.41x2.33x2.58x4.28x3.81x3.54x3.92x3.52x
Goodwill811.45M816.38M780.03M778.91M769.51M523.95M529.46M524M448M441.36M439.81M383.91M383.65M28.52M28.52M28.52M28.52M26.66M26.66M26.36M25.25M13.33M6.37M6.37M6.4M000000
Intangible Assets156.46M163.29M165.05M191.21M213.29M94.67M121.66M143.92M105.98M128.07M147.48M134.91M160.39M15.13M18.86M22.71M26.65M26.5M29.99M33.45M6.91M2.15M637K1.27M2.24M9.55M4.09M5.1M6.1M2.9M2M
Long-Term Investments7.43M3.72M3.86M4.08M4.29M-46.45M-51.36M-56.43M4.9M4.8M4.55M-810K-1.39M-893K-47.97M-556K-552K-891K0-515K00000000000
Other Non-Current Assets18.69M14.42M13.46M12.87M-51.96M11.67M11.33M8.62M-42.49M-48.28M1.87M5.06M4.34M541K47.91M474K420K60K59K61K000000000100K0
Total Assets1.69B1.71B1.58B1.6B1.62B1.2B1.17B1.16B981.36M963.64M948.63M881.22M861.27M376.87M312.55M271.72M228.62M187.81M154.47M154.42M92.33M75.14M60.41M56.91M53.3M44.48M23.22M22M22.6M17.6M15.1M
Asset Turnover0.63x0.61x0.61x0.58x0.58x0.67x0.60x0.56x0.66x0.62x0.58x0.63x0.63x0.89x0.99x1.07x1.12x1.17x1.50x1.14x1.09x11.17x1.12x1.09x1.13x1.04x1.43x1.35x1.27x1.63x1.75x
Asset Growth %23.67%8.39%-1.37%-1.68%35.45%2.87%0.88%17.76%1.84%1.58%7.65%2.32%128.53%20.58%15.03%18.85%21.73%21.58%0.03%67.25%22.88%24.4%6.15%6.77%19.83%91.53%5.55%-2.65%28.41%16.56%5.59%
Total Current Liabilities152.54M176.38M157.69M148.49M140.04M143.8M94.43M92.26M82.06M108.4M101.01M81.12M95.52M35.75M30.23M30.91M29.51M33.81M25.68M36.33M9.56M9.15M5.71M6.08M7.93M6.48M3.28M2.8M3.5M3.6M3.5M
Accounts Payable060.42M54.74M55.5M57.32M56.24M23.74M37.27M33.79M28.45M32.51M14.71M24.35M12.39M14.28M11.53M9.76M10.88M10.34M11.19M3.01M2.56M1.47M1.25M2.78M2.88M970K600K1.1M2.7M2.5M
Days Payables Outstanding23.7433.0932.3632.6631.6136.9318.0631.4628.0725.5931.8713.9722.3818.8723.5920.4420.1126.0321.0231.616.4217.1912.2711.2427.4937.3220.6514.0425.7464.4166.61
Short-Term Debt33.71M3.82M000000035M35M35M35M001.39M1.48M6.78M4.9M10.59M0001.74M1.74M1.75M0600K1.2M800K700K
Deferred Revenue (Current)00000000000000040K00042K00000000000
Other Current Liabilities118.83M77.18M22.89M71.54M62.15M65.63M48.6M41.46M2.26M13.85M12.09M13.46M11.42M7.86M4.14M4.29M13.56M005.83M4.68M4.83M2.75M389K382K305K521K1.6M1.2M100K300K
Current Ratio2.55x2.07x1.99x2.12x2.40x2.24x2.83x2.76x2.76x1.84x1.87x2.45x1.90x7.77x7.01x5.68x4.39x2.75x2.15x1.44x3.02x3.85x5.12x3.89x2.37x2.63x3.47x3.25x2.40x2.03x1.60x
Quick Ratio1.59x1.33x1.16x1.38x1.54x1.61x2.08x1.85x1.94x1.28x1.30x1.88x1.38x7.07x6.32x5.08x3.86x2.34x1.50x1.01x1.98x2.92x4.01x2.91x1.46x1.77x2.69x2.29x1.57x1.33x1.06x
Cash Conversion Cycle100.7389.4390.7681.3585.3476.4986.6192.3584.1984.9979.1769.7571.7561.5659.9955.6758.1655.8860.3674.0879.5745.1183.9384.8687.5491.289.1898.2984.0834.7925.49
Total Non-Current Liabilities256.09M273.76M267.77M394.74M546.19M178.51M243.18M319.76M207.68M238.36M326.58M336.4M373.85M9.76M9.3M8.79M11.65M6.86M14.28M25.01M7.41M5.06M4.46M11.05M12.1M12.67M362K1.3M3.3M1.7M2.2M
Long-Term Debt33.71M175.32M190M309.57M440.57M108.57M163.57M248.57M156M183.96M245.49M260.96M297.5M03.43M23K3.43M06.67M17.4M0007.84M9.58M11.32M0700K2.6M800K1.4M
Capital Lease Obligations40.53M12.87M14.72M16.54M16.02M7.11M6.08M4.83M00000000000000000000000
Deferred Tax Liabilities224.2M75.45M43.72M52.05M62.78M46.45M51.36M56.43M44.31M48.55M74.2M67.22M70.4M5.88M5.87M5.98M5.64M5.03M6M6.09M6.63M4.01M3.46M2.23M1.56M351K225K400K500K500K500K
Other Non-Current Liabilities169M10.12M19.34M16.58M26.81M16.37M22.18M9.93M7.37M5.85M6.9M6.68M5.95M3.88M02.79M2.58M1.82M1.61M1.53M784K1.04M1M985K964K994K137K200K200K400K300K
Total Liabilities408.63M450.15M425.46M543.23M686.23M322.31M337.61M412.01M289.74M346.75M427.59M417.52M469.37M45.51M39.53M39.71M41.16M40.67M39.97M61.34M16.97M14.21M10.17M17.13M20.03M19.14M3.64M4.1M6.8M5.3M5.7M
Total Debt33.71M192.01M208.04M330.33M460.61M118.04M171.99M255.87M156M218.96M280.49M295.96M332.5M3.88M3.43M1.41M4.91M6.78M11.57M27.99M0009.58M11.32M13.07M01.3M3.8M1.6M2.1M
Net Debt-39.16M117.44M158.53M265.89M394.05M14.8M87.41M190.2M101.73M178.55M241.85M211.17M282.21M-204.87M-141.31M-113.37M-72.34M-39.65M8.15M25.68M-5.19M-13M-12.73M342K9.59M9.95M-3.07M-400K2.5M900K2M
Debt / Equity0.03x0.15x0.18x0.31x0.49x0.13x0.21x0.34x0.23x0.35x0.54x0.64x0.85x0.01x0.01x0.01x0.03x0.05x0.10x0.30x---0.24x0.34x0.52x-0.07x0.24x0.13x0.22x
Debt / EBITDA0.13x0.73x0.90x1.54x2.34x0.67x1.06x1.72x1.03x1.55x2.05x2.21x2.95x0.05x0.05x0.02x0.08x0.14x0.31x0.87x---0.76x0.75x1.21x-0.19x0.58x0.30x0.47x
Net Debt / EBITDA-0.15x0.45x0.69x1.24x2.00x0.08x0.54x1.28x0.67x1.26x1.76x1.58x2.50x-2.69x-2.04x-1.73x-1.24x-0.81x0.22x0.80x-0.23x-0.66x-0.79x0.03x0.64x0.92x-0.39x-0.06x0.38x0.17x0.44x
Interest Coverage15.23x20.48x11.07x7.07x14.03x51.99x24.97x17.19x14.01x12.73x12.41x14.21x15.98x2743.42x5985.40x676.45x558.01x195.27x30.52x------------
Total Equity1.29B1.26B1.15B1.05B938.28M877.01M828.23M743.67M691.62M616.88M521.03M463.7M391.9M331.36M273.01M232.01M187.47M147.14M114.51M93.08M75.36M60.93M50.23M39.78M33.27M25.33M19.58M17.9M15.8M12.3M9.4M
Equity Growth %39.9%9.35%9.1%12.33%6.99%5.89%11.37%7.53%12.12%18.4%12.36%18.32%18.27%21.37%17.67%23.76%27.4%28.5%23.02%23.51%23.68%21.3%26.28%19.57%31.33%29.38%9.39%13.29%28.46%30.85%27.03%
Book Value per Share39.8138.5735.1532.4828.9726.8425.4822.8821.3219.1416.3214.6612.5710.748.997.676.335.104.013.352.742.261.921.571.331.030.810.720.620.500.40
Total Shareholders' Equity1.29B1.26B1.15B1.05B938.28M877.01M828.23M743.67M691.62M616.88M521.03M463.7M391.9M331.36M273.01M232.01M187.47M147.14M114.51M93.08M75.36M60.93M50.23M39.78M33.27M25.33M19.58M17.9M15.8M12.3M9.4M
Common Stock2.14M2.14M2.17M2.15M2.15M2.15M2.16M2.16M2.15M2.13M2.12M2.1M2.06M2.02M1.96M1.94M1.92M1.87M823K804K788K776K508K327K327K327K327K300K000
Retained Earnings1.16B1.12B997.49M897.49M814.49M732.14M656.74M590.92M528.03M464.64M388.09M344.2M295.2M251.63M214.61M181.07M147.54M118.58M94.88M77.84M63.99M53.31M43.4M36.06M30.81M23.77M18.97M15.5M12.7M9.9M7.3M
Treasury Stock000000-7.87M-18.07M-56K00-74K000000000-1.16M0-504K-1.41M-2.15M-2.8M-900K000
Accumulated OCI31.75M41.55M-23.75M8.69M-7.15M-4.99M4.17M-5.56M-3.6M-1.64M-6.85M-5.11M-2.65M198K-759K-938K-549K153K-8K150K193K-17.93M-15.35M-12.82M-11.02M-9.19M-7.86M-7M-6M-5.2M-7.2M
Minority Interest0000000000000000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Regulatory Ethylene Oxide Exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Deleveraging Enhances Financial Flexibility

According to recent SEC filings, Balchem has significantly strengthened its balance sheet by reducing total debt from $330.3 million in 2023Q4 to just $33.7 million by 2026Q1, signaling a transition toward a net-cash position that provides substantial insulation against potential macroeconomic volatility or future capital requirements.

The consistent reduction in debt levels over the past ten quarters suggests a management team prioritizing fiscal conservatism and balance sheet optionality. This trajectory indicates that the company is effectively utilizing its strong cash flow to deleverage, which may lower the cost of capital and provide a buffer for future strategic investments.

Minimal Leverage Supports Defensive Positioning

Based on reported financial statements, Balchem's debt-to-equity ratio has compressed from 0.31 in 2023Q4 to a negligible 0.03 in 2026Q1, reflecting a strategic shift that minimizes interest expense and mitigates refinancing risks in an environment of fluctuating interest rates.

The near-elimination of debt suggests that the company is not reliant on external financing to fund its operations or R&D initiatives. This lack of leverage is a key differentiator compared to peers, potentially allowing the firm to maintain its R&D and acquisition pace even if credit markets tighten.

Intangible Assets Dominate Asset Base

As reported in quarterly balance sheets, goodwill remains a significant component of total assets at $811.5 million as of 2026Q1, representing nearly 48% of the total asset base, which warrants close monitoring for potential impairment risks related to past acquisitions.

The high concentration of goodwill and intangibles reflects the company's history of acquiring specialized intellectual property to bolster its product portfolio. While this supports the competitive moat, investors should monitor whether these assets continue to generate the expected returns on invested capital to justify their carrying values.

Robust Liquidity Buffers Operational Needs

Based on the provided data, Balchem maintains a healthy current ratio of 2.55 as of 2026Q1, indicating that the company possesses sufficient short-term assets to cover its immediate obligations without relying on external credit facilities or aggressive working capital management.

The consistent current ratio, which has remained above 2.0 for the majority of the last ten quarters, suggests a stable liquidity profile that supports ongoing operational requirements. This liquidity buffer appears adequate to handle potential regulatory-driven capital expenditures without compromising the company's ability to meet its short-term liabilities.

Retained Earnings Drive Equity Growth

According to historical balance sheet data, retained earnings have grown steadily from $897.5 million in 2023Q4 to $1.2 billion in 2026Q1, demonstrating that internal capital generation is the primary driver of equity expansion rather than external dilution.

The consistent accumulation of retained earnings underscores the profitability of the underlying business model and the effectiveness of management's capital allocation strategy. This trend suggests that the company is successfully reinvesting its profits to build long-term shareholder value while maintaining a clean capital structure.

BCPC — Frequently Asked Questions

Quick answers to the most common questions about buying BCPC stock.

What are the total assets of Balchem Corporation (BCPC)?

As of 2025, Balchem Corporation (BCPC) had total assets of $1.71B including $365.6M in current assets.

How much debt does Balchem Corporation (BCPC) have?

Balchem Corporation (BCPC) carries total debt of $192.0M, offset by $74.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Balchem Corporation?

Balchem Corporation (BCPC) has total shareholders' equity (book value) of $1.26B ($38.57 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Balchem Corporation's current ratio and liquidity?

Balchem Corporation (BCPC) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.